| Tag | Content |
|---|
EnhancerAtlas ID | HS108-35147 |
Organism | Homo sapiens |
Tissue/cell | K562 |
Coordinate | chr6:88431940-88433960 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NEUROG2 | MA0669.1 | chr6:88433765-88433775 | AACATATGTC | + | 6.02 | | NFE2L1 | MA0089.2 | chr6:88433195-88433210 | CCATGAGTCAGCAGA | + | 6.14 | | Nfe2l2 | MA0150.2 | chr6:88433193-88433208 | AACCATGAGTCAGCA | + | 6.82 | | ZNF263 | MA0528.1 | chr6:88433296-88433317 | AGAGGAGAGAGAGAGAGAGAA | + | 6.3 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_09393 | chr6:88432187-88433607 | CD14 | | SE_36435 | chr6:88432079-88434128 | HMEC | | SE_64803 | chr6:88433126-88433945 | NHEK |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH06I087722 | chr6 | 88431869 | 88436153 |
|
Enhancer Sequence | GAACTCCTGA CCTCGTGATC CACGCTCCCC ACCCCTCCTC CACCGCCAAA GTGCTTGGAT 60
TACAGACGTG AGCCACCACA TCCAGCCGGA TGCCCAGATT TTTAAAAGAA ACTTGAGTAG 120
GTTGAGAAAT TAAGATCCTC ACCAGGATAA TTGTTACTTT TCTAAGTGTT TCCCTTTGGA 180
TCCTTCCTTT CTTCATAGGA ACATACTAAA CGTTCAATGC CACAATGGAT TTCAATGGGG 240
AAAAACTAAT CTTGCTTTGT AGACAACTTT ACAGGAATGC CTCAGTTTCA TACACTGCAG 300
GATAGTTGTA TTAATTTGGC ATAGATAGAA ATTTCAATTA ACATAGTCTT TTTTCTTTAT 360
TTGCAGCAGT TCACCAACAA TGCATTTTAG AGCATTGCTC ACCCTCAGCA TTAGAACTGA 420
GTGAATCTTC TGTTGAAATG GAGGCATCTA TTCACCACAT TACTTTTTCA AGCCTCTAAC 480
ACCTTAACAG GCAAACCTCA GAGGAAGGTC TGCTTTCCTC TTCCTTTAGA AATCCCCCCT 540
AAGCAAGAAA CATTTGCTGA ATGCCTAGCT GGGGACTTCA ACATTGTTAG CACATGTGAG 600
CAGCCTTCCA AAACTGTTTA CAGTAATGGT AACGTTGGTA ATAATACACC ATTGGACTTA 660
CTGCAAAGAC AATTTTTTCA ATGTTTGTTC ATATAAAACC TGCCAAATTG TCGATATTAG 720
AGTTGGTCAT TCCTTACATT ATGAGATTCC TAAAATGAAA ATAGCAGTAA TAGATCCTGA 780
GAGCTGTGAG GTCATTTTGT TCAGTTTACA TATTAAGGAC ATGAGTCTTT GGAAGATTAG 840
GAAAGTTGTC TATAGTTTCA TGACTACGAA ATGGCAGATT TTTTTTTTCC AAACCCCATG 900
CATTTTTTTT TAATCACAAC CGTGCATGCC TCTCTCAGCC CCATATCTGC CCCAGAGATG 960
TCAAACATTC CCTCCTCCCT ACCCATATAC TGCCTTGGAG ACTCTACCCC GCTCCTAACT 1020
TGGAAGAGAG AGTACTACCT GCCATGTGAC TGTGCCCCAT CAGTCTCAGT TACTGACCCA 1080
GGAGTAGACA TCTGACTCAA ACTGGGTTGA TCGAATTCTC TCCCAGGAAT TTGGAATAGG 1140
GACAAAGAGG CTGAGTCATT TAGCTGTGTG GAGCCAAGCT GCAAGGTCAT GCCCAGCTGG 1200
CCTGCCACAG CAGGCCAAAA CCTCATGCTA GCCACAGTGA AGGGAAGCTG AGAAACCATG 1260
AGTCAGCAGA AAAAGCTCAT CTGCAAACAA AAGAGCACAA AGATGGGGCC GACTGATACT 1320
CAGAGTCAAA TAGAGAGGCC ATGTACCTCA AAAGGCAGAG GAGAGAGAGA GAGAGAAATA 1380
AAATCTGCAT AATCCCCTTC TTGGCCCTAT AATGCCCAGC AGCTGTATCT CCAGCGCTGG 1440
CTTACTGTGA CCCCCATAAT AACCTCTGCC TTTCAATCAA CCCTCTTTTT ATTTGAGTTA 1500
GTGGAATTCT GTTCCTTGCA TGCAAATTCT TCCTAAGACA CTTCACAATT CATATTGAAT 1560
ATATTTTGGG GTAGAAAGAC TATTCTGCTC TTTATGACGA TTATGGAAAT TGAGGTTTTA 1620
TCTCAAAACC CACAACAGGC TGAGCAGCTT TCGGCATTCT CGCCACTAAT TATCCAGACT 1680
CCGGAGACTG AGCTTTCAAG GTGAGTGGTT TTCAGAACTG CAAATGAGAG CCAGCCCCAT 1740
TCTGGGTCTC TTTCCCCAAG GATATCTTAG AGATATTCAG TTCAGGAAGA GAGGTCTTAT 1800
TGTAGTATGT AGTTGCCATC TTGGGAACAT ATGTCAGGAC TTCCTAAAGT CTTTCTGCTT 1860
AAAGTTTCCA AGAAAGTATG GAGCCTGATT TCTCATAAAG CCACTTTTCC TTTAAAGGTA 1920
CTTGTGGAAT CTCTATAGGC CCAAGGTTGA CATGACCATA TCCGTGAAAA GCTCAGGTAC 1980
TATTTCTGTG CTAATCTCTT TAGAATAACA GAAAGAATTT 2020
|
